scholarly article | Q13442814 |
P50 | author | Kevin J. Tracey | Q6396583 |
Ulf Andersson | Q37375023 | ||
Haichao Wang | Q37375045 | ||
P2093 | author name string | Ben Lu | |
P2860 | cites work | Novel role of PKR in inflammasome activation and HMGB1 release | Q24293509 |
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4 | Q24306365 | ||
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release | Q24321082 | ||
The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway | Q24538824 | ||
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome | Q24655696 | ||
Regulation of inflammasome signaling | Q26996605 | ||
Structures of the HIN Domain:DNA Complexes Reveal Ligand Binding and Activation Mechanisms of the AIM2 Inflammasome and IFI16 Receptor | Q27678368 | ||
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation | Q28131815 | ||
HMG-1 as a late mediator of endotoxin lethality in mice | Q28139166 | ||
Non-canonical inflammasome activation targets caspase-11 | Q28506831 | ||
Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity | Q28508255 | ||
Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis | Q28510028 | ||
HMGB1 protein inhibits DNA replication in vitro: a role of the acetylation and the acidic tail | Q28582836 | ||
Inflammasomes in health and disease | Q29616356 | ||
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion | Q33193752 | ||
Inflammation 2010: new adventures of an old flame | Q34105595 | ||
New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal | Q34334123 | ||
High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity | Q34400931 | ||
HMGB1 is a therapeutic target for sterile inflammation and infection | Q35953553 | ||
Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia | Q36190954 | ||
Role of HMGB1 in apoptosis-mediated sepsis lethality | Q36228722 | ||
Sensing and reacting to microbes through the inflammasomes | Q36253171 | ||
NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. | Q36839608 | ||
Caspase-1-induced pyroptotic cell death | Q37925075 | ||
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? | Q37995073 | ||
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. | Q39473693 | ||
Antibodies against chromosomal HMG proteins stain the cytoplasm of mammalian cells | Q41004026 | ||
The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. | Q41463392 | ||
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release | Q42321499 | ||
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures | Q43116251 | ||
Nonhistone Proteins HMG 1 and HMG 2 Change the DNA Helical Structure | Q44863866 | ||
Mechanistic Link between PKR Dimerization, Autophosphorylation, and eIF2α Substrate Recognition | Q57236276 | ||
Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes | Q80633588 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammasome complex | Q412405 |
P304 | page(s) | 163-7 | |
P577 | publication date | 2013-03-01 | |
P1433 | published in | Protein & Cell | Q26854012 |
P1476 | title | Regulation of HMGB1 release by inflammasomes | |
P478 | volume | 4 |
Q88072187 | ATP/P2X7-NLRP3 axis of dendritic cells participates in the regulation of airway inflammation and hyper-responsiveness in asthma by mediating HMGB1 expression and secretion |
Q58123949 | Activation of NLRP3 Inflammasome Promotes Foam Cell Formation in Vascular Smooth Muscle Cells and Atherogenesis Via HMGB1 |
Q41965068 | Adsorption of the inflammatory mediator high-mobility group box 1 by polymers with different charge and porosity |
Q92330254 | Amentoflavone ameliorates cold stress-induced inflammation in lung by suppression of C3/BCR/NF-κB pathways |
Q55347993 | Association of Inflammatory Responses and ECM Disorganization with HMGB1 Upregulation and NLRP3 Inflammasome Activation in the Injured Rotator Cuff Tendon. |
Q39127408 | Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation |
Q34381495 | Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis |
Q36088701 | Cobalt Alloy Implant Debris Induces Inflammation and Bone Loss Primarily through Danger Signaling, Not TLR4 Activation: Implications for DAMP-ening Implant Related Inflammation |
Q48212821 | Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs |
Q37409524 | Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection |
Q89967548 | Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease |
Q27005695 | Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology |
Q26782785 | DAMPs from Cell Death to New Life |
Q41117279 | Damage-Associated Molecular Pattern and Fetal Membrane Vascular Injury and Collagen Disorganization in Lipopolysaccharide-Induced Intra-amniotic Inflammation in Fetal Sheep |
Q47659090 | Danger signals: Chemotherapy enhancers? |
Q37683948 | Double-stranded RNA induces inflammation via the NF-κB pathway and inflammasome activation in the outer root sheath cells of hair follicles. |
Q33684145 | Emerging role of HMGB1 in lung diseases: friend or foe. |
Q91474364 | Entamoeba histolytica stimulates the alarmin molecule HMGB1 from macrophages to amplify innate host defenses |
Q92237102 | Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells |
Q38752410 | Exosomes from NSC-34 Cells Transfected with hSOD1-G93A Are Enriched in miR-124 and Drive Alterations in Microglia Phenotype. |
Q39016000 | Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization |
Q90364624 | G2A Protects Mice against Sepsis by Modulating Kupffer Cell Activation: Cooperativity with Adenosine Receptor 2b |
Q104795085 | Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms |
Q52665601 | Glutathione S-Transferase Pi Prevents Sepsis-Related High Mobility Group Box-1 Protein Translocation and Release. |
Q64229433 | HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma |
Q38939435 | HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins |
Q30406863 | Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses |
Q92126449 | High Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction |
Q62734453 | High mobility group box 1 as a biomarker in critically ill patients |
Q34044574 | High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD). |
Q36169636 | Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces Cytoplasmic Interferon-β Responses. |
Q36620651 | Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. |
Q63560422 | Inflammasome Signaling and Impaired Vascular Health in Psoriasis |
Q60303389 | Inflammasomes: Pandora's box for sepsis |
Q28392019 | Inhibiting the inflammasome: one domain at a time |
Q37612678 | JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation |
Q89964070 | Kaempferol Improves Lung Ischemia-Reperfusion Injury via Antiinflammation and Antioxidative Stress Regulated by SIRT1/HMGB1/NF-κB Axis |
Q36101917 | Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators |
Q27009559 | Microglia centered pathogenesis in ALS: insights in cell interconnectivity |
Q26795583 | Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses |
Q47274393 | Minocycline Attenuates High Mobility Group Box 1 Translocation, Microglial Activation, and Thalamic Neurodegeneration after Traumatic Brain Injury in Post-Natal Day 17 Rats |
Q36265872 | Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. |
Q30854108 | Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy |
Q27009468 | Novel Mechanisms of Herbal Therapies for Inhibiting HMGB1 Secretion or Action |
Q92377619 | Novel circulating- and imaging-based biomarkers to enhance the mechanistic understanding of human drug-induced liver injury |
Q34999938 | Novel drugs targeting Toll-like receptors for antiviral therapy |
Q34303351 | Phosphoproteomics combined with quantitative 14-3-3-affinity capture identifies SIRT1 and RAI as novel regulators of cytosolic double-stranded RNA recognition pathway. |
Q92755416 | Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases |
Q92382641 | Poly (ADP-ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation-associated chemotherapy-induced autophagy in leukaemia cells |
Q40489303 | Porphyromonas gingivalis attenuates ATP-mediated inflammasome activation and HMGB1 release through expression of a nucleoside-diphosphate kinase. |
Q38682450 | Regulation of Posttranslational Modifications of HMGB1 During Immune Responses |
Q39000251 | Role of ROS and HMGB1 in contact allergen-induced IL-18 production in human keratinocytes |
Q52151935 | S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis. |
Q37622744 | Targeting HMGB1 in the treatment of sepsis |
Q38748531 | Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy. |
Q36814026 | The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome |
Q57120217 | The role of high mobility group box 1 protein in acute cerebrovascular diseases |
Q90176082 | Toddalolactone Protects Lipopolysaccharide-Induced Sepsis and Attenuates Lipopolysaccharide-Induced Inflammatory Response by Modulating HMGB1-NF-κB Translocation |
Q34655362 | Ultraviolet light exposure stimulates HMGB1 release by keratinocytes |
Q61804693 | Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells |
Q38556787 | rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner |
Q34420936 | α7 nicotinic acetylcholine receptor signaling inhibits inflammasome activation by preventing mitochondrial DNA release |
Search more.